Autres langues CytoMed Therapeutics Limited

Actions

GDTC

SGXZ17669631

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
2,24 ^USD	+14,29 %		+4,19 %	-54,29 %

24/05	CytoMed Therapeutics Limited approuve la démission de Wu Tao Thomas et du Dr. Lucas Luk Tien Wee en tant qu'administrateurs	CI
22/04	CytoMed Therapeutics Limited annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers	17/07
CytoMed Therapeutics : Board re organization Form 6 K	20/06
CytoMed Therapeutics : Annual Shareholders Meeting - Form 6-K	24/05
CytoMed Therapeutics Limited Announces Board and Audit Committee Changes	24/05
CytoMed Therapeutics : PROXY STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	24/04
CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	22/04
Certain Ordinary Shares of CytoMed Therapeutics Limited are subject to a Lock-Up Agreement Ending on 14-APR-2024.	14/04
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies	18/03
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies	18/03
CytoMed Therapeutics Limited to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies	18/03
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair	04/03
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair	04/03
CytoMed Therapeutics Limited Announces Research Collaboration with Sengkang General Hospital Pte Ltd to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair	04/03
CytoMed Therapeutics Receives Patent in Malaysia for its Prospective Cancer Therapy	29/01
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology	29/01
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology	29/01
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology	05/12
CytoMed Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2023	17/11
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update	17/11
CytoMed Therapeutics to Present at the Benchmark Company s Upcoming Discovery One-on-One Investor Conference	15/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CytoMed Therapeutics Limited

Actions

GDTC

SGXZ17669631

Autres langues

Filtres